Effects of short term forced oral breathing: Physiological changes and structural adaptation of diaphragm and orofacial muscles in rats

2011 ◽  
Vol 56 (12) ◽  
pp. 1646-1654 ◽  
Author(s):  
Guy Stéphane Padzys ◽  
Jean-Marc Martrette ◽  
Christiane Tankosic ◽  
Simon Nigel Thornton ◽  
Marie Trabalon
2018 ◽  
Vol 41 ◽  
pp. S30
Author(s):  
Larry Hou-Yan Ng ◽  
Zhaoran Wang ◽  
Cheuk-Yin Chan ◽  
Wang-Ngai Yuen

2015 ◽  
Vol 177 ◽  
pp. 93-99 ◽  
Author(s):  
Karina I. Silva ◽  
Cristina R.G. Sales ◽  
Paulo E.R. Marchiori ◽  
Neidiquele M. Silveira ◽  
Eduardo C. Machado ◽  
...  

1997 ◽  
Vol 110 (1-2) ◽  
pp. 119-134 ◽  
Author(s):  
Renaud Charlet de Sauvage ◽  
Deise Lima da Costa ◽  
Jean-Paul Erre ◽  
Jean-Marie Aran

2011 ◽  
Vol 102 (2) ◽  
pp. 175-180 ◽  
Author(s):  
Guy S. Padzys ◽  
Simon N. Thornton ◽  
Jean-Marc Martrette ◽  
Marie Trabalon

Author(s):  
J.Person Le Ruyet ◽  
G Boeuf ◽  
J.Zambonino Infante ◽  
S Helgason ◽  
A Le Roux

2020 ◽  
Author(s):  
Maria Poley ◽  
Yael Shammai ◽  
Maya Kaduri ◽  
Lilach Koren ◽  
Omer Adir ◽  
...  

AbstractThroughout the female menstrual cycle, physiological changes occur that affect the biodistribution of nanoparticles within the reproductive system. This can have positive or negative effects. We demonstrate a 2-fold increase in nanoparticle accumulation in the ovaries during female mouse ovulation compared to the non-ovulatory stage following intravenous administration. Accumulation in the reproductive system is favored by nanoparticles smaller than 100 nm. Chemotherapeutic nanoparticles administered during ovulation increased ovarian toxicity and decreased short-term and long-term fertility when compared to the free drug. Breast cancer treated with nanomedicines during ovulation results in higher drug accumulation in the reproductive system rather than at the site of the tumor, reducing treatment efficacy. Conversely, ovarian cancer treatment was improved by enhanced nanoparticle accumulation in the ovaries during ovulation. Our findings suggest that the menstrual cycle should be considered when designing and implementing nanotherapeutics for females.


Ergonomics ◽  
2009 ◽  
Vol 52 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Amrish O. Chourasia ◽  
Mary E. Sesto ◽  
Walter F. Block ◽  
Robert G. Radwin

2013 ◽  
Vol 59 ◽  
pp. 438-445 ◽  
Author(s):  
Oliver A.H. Jones ◽  
Steven Murfitt ◽  
Claus Svendsen ◽  
Anthony Turk ◽  
Hazel Turk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document